The Framingham risk score (FRS) is one of the standard tools used to predict the incidence of coronary heart disease (CHD). No previous study has investigated its efficacy for a Japanese population cohort. The purpose of this study was to develop new coronary prediction algorithms for the Japanese population in the manner of the FRS, and to compare them with the original FRS. Methods: Our coronary prediction algorithms for Japanese were based on a large population-based cohort study (Suita study). The study population comprised 5,521 healthy Japanese. They were followed-up for 11.8 years on average, and 213 cases of CHD were observed. Multiple Cox proportional hazard model by stepwise selection was used to construct the prediction model. 
Introduction
The Framingham Heart Study identified the classic risk factors for coronary heart disease (CHD) 1) , and it developed multivariable predictive instruments, which enable clinicians to estimate the 10-year individual risk of developing CHD 2, 3) . These findings have also been widely adopted in clinical guidelines 4, 5) . However, the FRS cannot be generalized for other populations, since 99% of the Framingham cohort participants were Caucasian 5) . For example, the use of the FRS in some other populations resulted in an overestimation of the CHD risk [6] [7] [8] .
Definition of CKD
The serum Cre level was measured using the noncompensated kinetic Jaffe´ method. The estimated There has been relatively little attention paid to the validity of the FRS in the Japanese population, which constitutes a unique population in many aspects, with a markedly lower incidence of CHD than Western populations 9) . To our knowledge, no previous Japanese cohort study has been performed to evaluate the original and recalibrated FRS.
Several Japanese cohort studies developed risk prediction tools for Japanese patients. The NIPPON DATA 80 prediction tool has been used as the standard prediction tool in Japan 10) , and has been adopted by some clinical guidelines for the stratification of risk in Japanese subjects 11) . However, the NIPPON DATA 80's outcome measure was coronary death, not the incidence of CHD. The Hisayama study predicted a composite outcome of stroke and CHD 12) . Noda's prediction score also applied to cardiac mortality 13) . The JALS study group developed a prediction tool for acute myocardial infarction (AMI), but their prediction period was relatively short (five years) 14) . The JMS-cohort study chart was also targeted for AMI, but the population was limited to rural residents 15) . These tools are all associated with some advantages and disadvantages. However, additional tools for the prediction of CHD are needed that can accurately assess the risk of the longer-term incidence of CHD in the Japanese population.
In this context, we have developed a new algorithm, named the Suita Score, for predicting the 10-year probability of developing CHD, which is based on the findings of a large population-based cohort study performed in an urban area in Japan.
Furthermore, chronic kidney disease (CKD) has recently been advocated as an independent risk factor for CHD, and patients with CKD tend to possess multiple CVD risk factors, and thus represent a major public health problem 16, 17) . A recent CHD risk assessment tool based on 2.3 million patients, the QRISK2, included CKD as a necessary component for the risk prediction 18) . Moreover, CKD patients tend to have an underestimated CHD risk based on the FRS 19) . In addition, we previously reported that CKD leads to an increased risk of both MI and stroke 20) . Hence, the objective of this study was; 1) To incorporate established classic coronary risk factors into newly developed coronary prediction algorithms for the Japanese population, 2) To compare the discriminatory properties of this approach with those of the original and recalibrated FRS in the Suita cohort. The probability function was:
where S(t) is the survival rate for the mean values of the risk factors at 10 years in the Suita study; β1 . . . βn are the regression coefficients of the Cox model (β) shown in Table 3 ; X1 . . . Xn represent the individual risk factor values of each study participant and M1 . . . Mn are the mean values of the risk factors in the Suita cohort. In the recalibrated Framingham functions, the coefficients were taken from the Framingham Cox model, but the mean values from the Suita cohort were used for the risk factors and the mean incidence rates 6) . Discrimination and calibration were used to evaluate the predictive capabilities of the models. We evaluated the discriminatory ability of this model by comparing the means of the C-statistics and Bayesian information criteria (BIC). Furthermore, we measured the model improvement as indicated by the clinical reclassification of the FRS by the Suita Score, which is considered to be more important indicator for predictive ability using the net reclassification improvement (NRI) 28) . Since the inclusion of a new biomarker in a prediction tool , such as the FRS, minimally improves the predictive ability, the evaluation based on the NRI is considered to be a valid approach for evaluating the new biomarker 29) . The NRI measures the reclassification of people from one risk category to another resulting from the addition of the new risk factor to a prediction model with established risk. If all of the people end up in a more correct risk class based on the model with the new marker, the NRI is positive. We calculated the category-free NRI 30) . The third approach was calibration, which measured how closely the predicted risk fit the actual risk. The Suita participants were divided into quintiles of 10-year CHD risk predicted by the Suita score functions, the original Framingham functions and the recalibrated Framingham functions 6) . The predicted and actual risk in each quintile were compared, and the differences were assessed by the Hosmer-Lemeshow chi-square tests. The SAS software program, version 9.3. (SAS Institute Inc), and the STATA software program, version 12 (STATA Corp LP), were used for all of the statistical analyses.
Results

Population Characteristics
The number of person-years studied consisted of 75,776 (34, 0.742 (for females).
The CKD stage was defined by the K/DOQI clinical practice guidelines 26) . CKD was categorized into Stage 3 CKD (eGFR 30-60 ml/min/1.73m
2 ) and Stage 4 or 5 CKD (eGFR＜30 ml/min/1.73m
2 ).
Endpoint Determination
The follow-up method used in the Suita study has been reported previously [20] [21] [22] [23] [24] . The endpoints for the current follow-up study were: (1) the date of the first diagnosis of CHD (2) the date of death, (3) the date when the subject left Suita or (4) censoring by December 31, 2007 .
The first step in the survey for CHD involved checking the health status of all the participants at clinical visits carried out every two years, and by yearly questionnaires sent by mail or conducted by telephone. The second step involved the review of in-hospital medical records of participants who were suspected to have developed CHD. The criteria for definite or probable acute myocardial infarction were the same as the criteria used for the MONICA project 27) . In order to complete the surveillance for fatal MI, we also conducted a systematic search of death certificates. In addition to acute myocardial infarction, the criteria for a diagnosis of CHD included sudden cardiac death within 24 hours after the onset of acute symptoms, or CHD followed by coronary artery bypass or angioplasty.
Statistical Analysis
First, we evaluated the validity of categorical variables in the Suita Score to compare them with the original FRS 3) . Then, we conducted a multiple Cox proportional hazard model using the same categories as those in the FRS. Subsequently, we developed a new CHD risk score for Japanese subjects based on the Cox model for the Suita cohort. Other risk factors were calculated using the same categories as the FRS. A stepwise selection with a p-value of 0.1 for backward elimination was used to select the best predictive model.
After selection of the best Cox model, we fitted the hazard functions developed by the Framingham investigators from the previously published data 6) for predicting the 10-year probability of developing CHD Table 1 . The univariate Cox regression analysis indicated all variables in FRS were statistically significant (data not shown). 
Validation of the Inclusion of CKD
The C-static of the Suita Score without CKD was slightly lower than the Suita Score with CKD (0.835 vs. 0.833). The comparison between the TC Suita Scores with and without CKD suggested that the addition of CKD improved the risk classification of CHD by 40%. This suggested that the inclusion of CKD in the risk prediction tool improves the prediction of the development of CHD, making it a more appropriate predictive tool. Table 7a shows the model fit, C-statistics and BIC of the Cox regression for the TC Suita Score, the original FRS and the recalibrated score for the mean value of each of the covariates. The TC Suita Score with CKD showed the best goodness-of-fit by the likelihood ratio test, and the C-statistics of the TC Suita Score with CKD were also the highest. The BIC was the lowest for the TC Suita Score with CKD, which supported its better predictive ability. The C-statistics were not changed by the recalibration of the FRS. The C-statistics of the recalibrated FRS were still smaller than the TC Suita Score with CKD.
Comparison of the Suita Score and Framingham Risk Scores
The results of the clinical reclassification measured by the NRI are shown in Table 7b . The NRI for the TC Suita Score with CKD compared to the original FRS was 46.8% (P＜0.001). In both the CHD and non-CHD groups, the risk categories tended to be increased by the TC Suita Score with CKD. The NRI between the TC Suita Score with CKD and the recalibrated model was lower (25.4%), but the difference remained significant (P = 0.003). These associations also held for the TC Suita Score without CKD, the FRS and the recalibrated FRS. Fig. 2 depicts the actual and predicted probabilities of the 10-year risk of cardiac events by calibration. The FRS consistently overestimated the cardiac events in all quintiles. The overall 10-year calibration of the FRS and recalibrated FRS were worse than the TC Suita Score with CKD as determined by the HosmerLemeshow chi-square test (both p＜0.001). The largest difference between the actual rate and the predicted rate after recalibration was 13.9% (in the fifth quintile in males), compared with the difference of 14.5% for the FRS. The difference between the actual probability and the TC Suita Score with CKD was not significant (P = 0.18). The TC Suita Score with CKD model underestimated the risk of CHD in the fourth quintile, but the difference was only 2.2%. These findings consistently indicated that the FRS overestimates the CHD risk in the Japanese population.
hazard model using the same categories as those used in the FRS are shown in Table 2 . All hazard ratios (HRs) of categorical hypertension were higher than those of the original FRS. The HRs of smoking and DM for females were also higher than those of the original FRS (2.59 and 3.22, respectively). The HR of a TC between 200 and 239 for females was 0.58, which was lower than that of the FRS. The HRs of other variables were similar to those of the original FRS. Table 3 shows the best Cox model for the Suita cohort selected by a stepwise method with the total cholesterol categories. (TC Suita score) The multivariable adjusted HR for the association between CHD and Stage 3 CKD was 1.39 and that for Stage 4 and 5 CKD was 3.72, respectively. The HRs of the other predictors were similar between the with CKD and without CKD models. Table 4 shows the best Cox model for the Suita Score with CKD according to the cut-off levels of LDL-C and HDL-C proposed in the Japan Atherosclerosis Society (JAS) Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases 2012 11, 31) (LDL Suita Score). For convenient clinical use, we developed prediction sheets based on the TC and LDL Suita Scores ( Table 5 ). The beta coefficients corresponding to the Cox model were multiplied 10 times for categorical covariates and were rounded. For the age category, the midpoint of each category was multiplied by the β coefficients in Table 4 , and then multiplied 10 times. We added all these values corresponding to each individual risk, divided the number by 10, and then the corresponding probability of CHD was calculated from the equation: P = 1−S(t)^exp((sum of the points)/10) where S(t) is the baseline survival function of the Suita cohort.
Prediction Model Development and the Simplified Prediction Model for Clinical Use
The C-statistics of the LDL Suita Score with CKD in Table 4 , which corresponded to the AUC of the Cox proportional hazard model, was 0.831. This was very similar to the TC Suita Score shown in Table  3 , which had a C-index of 0.835 (Table 6a ). The likelihood ratio test was not conducted, since the categorical variables were different and these two models were not nested. The NRI between TC Suita Score with CKD and the LDL Suita Score with CKD was not significant (P = .0.256; Table 6b ). These findings suggest that the two models predict CHD with similar efficiency. the CHD risk in the Japanese population.
First, the risk profile of the Suita cohort proved to be considerably different from that of a Western population. The crude incidence rate of CHD in the original Framingham Cohort was 8.94 per 1000 person-years, while that of the Suita cohort was only 2.81 per 1000 person-years. The risks of hypertension, low HDL-C for males, and diabetes and smoking for females, in the Suita cohort were weighted higher than the risks in the Framingham cohort. This difference between the Suita and the Framingham cohorts constitutes a major concern for the application of the FRS in Japanese subjects, where the lower CHD incidence
Discussion
In this study, we demonstrated the predictive ability of newly developed coronary prediction algorithms for Japanese subjects developed in the manner of the FRS. Our findings can be summarized as follows: 1) the risk profile for CHD of a Japanese population was considerably different from that of the original Framingham Heart Study cohort; 2) The prediction of CHD obtained with the risk score based on the Suita cohort with CKD variables was superior to that of the FRS or recalibration of the FRS; 3) Clinical reclassification revealed that the FRS overestimates manner and the overestimation was more severe in the high risk groups. Furthermore, we found that CKD is an independent risk factor for CHD after adjusting for other predictors of the FRS. The cohorts in the Framingham Heart Study and the Offspring study showed no significant association between the presence of kidney disease and the incidence of CVD 36) although some collaborative analyses showed positive associations 17, 37) . Our result is essentially compatible with that of Weiner's study, which reported the HRs of CKD after adjustment of the FRS for whites and blacks 38) . No previous study has dealt with this association for Asian ethnicity as an additional covariate in the prediction tool, although many cohort studies in Japan have demonstrated a significant association between CKD and cardiovascular disease 20, 25, 39) . Finally, we developed a simple prediction sheet for the estimation of CHD based on the TC and LDL Suita Score. For the exact estimation, the beta-coefficient from the TC and LDL Suita Score are preferable. However, the calculation requires computational and different risk factor levels were observed [32] [33] [34] . Second, the discriminatory capability of the TC Suita Score with CKD is better than those of the original and recalibrated FRS. Although recalibration with the mean value of the risk factors and baseline survival functions for the study cohort improved the discriminatory capability for various ethnic groups in the U.S., China and the CKD population 6, 12, 16) , the recalibration did not improve the discriminatory capability in Japanese subjects. We believe this is probably due to the low incidence of CHD in Japan compared to Western and Chinese populations 35) . The relative risks of various factors were similar between Suita Study cohort and the Framingham cohort. Therefore, the difference between the two prediction tools heavily depends on the difference in the absolute risks between these two cohorts. Accordingly, the clinical reclassification pointed out that the FRS overestimated the risk of CHD in Japanese subjects, especially in the non-CHD group, since the baseline survival function, which was higher than that in the original FRS, affected the estimated risk in an exponential Table 3 . In each quintile, the mean predicted 10-year probabilities and actual probabilities were estimated. The Suita Score, the Suita Score with CKD shown in Table 3 . FRS, Framingham risk score. CHD, coronary heart disease.
were randomly selected from the population of Suita city. In addition, based on the urbanized nature of the study population, it may not be possible to apply this tool in the whole Japanese population. However, since the outcome of the Suita study was the development of CHD, we believe that this tool can be a complement to the NIPPON DATA 80 risk score adopted in the JAS 2012 guidelines 11) , in which the outcome was CHD mortality. The external validation of our score must be evaluated in other cohort studies, although a lack of external validation is a common problem with the existing Japanese risk prediction tools, including the NIPPON DATA 80, JALS, JMS cohort and Hisayama study. Considering the increasingly Westernized lifestyle in urban areas 52) , these tools should be re-evaluated using a consortium of cohort studies, which include both urban and rural areas, such as the Epoch-Japan study group 53) . Very recently, the new AHA/ACC Guideline on the Treatment of Blood Cholesterol recommended the use of the new Pooled Cohort Equations to estimate the 10-year CHD risk in both white and black males and females, aged 40-75 years, and the FRS is no longer used for risk assessment 54) . However, this guideline is known to inaccurately estimate the CHD risk for Asians, Therefore, the value of the Suita Score for Japanese subjects and other low risk Asian populations is still superior to other systems.
Third, besides CKD, new biomarkers that can predict the CHD risk are emerging [55] [56] [57] . However, our study could not access their importance as have other existing prediction tools for Japanese subjects. For, example, the QRISK included rheumatoid arthritis, atrial fibrillation and the BMI. These relatively common, but not classic, cardiac risk factors must also be evaluated in future studies.
In conclusion, for Japanese subjects, the Suita prediction score with the CKD category resulted in better CHD prediction than the original and recalibrated FRS.
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The present study was supported by an Intramural Research Fund (22-4-5) power, and the more simplified tool is as effective in the clinical setting as the original FRS, since both the models use beta coefficients and a simplified clinical score.
The incorporation of CKD yields limited improvement in the predictive capability in terms of C-statistics. However, the NRI and IDI showed marked improvement by the incorporation of CKD, which is a more clinically relevant index for prediction improvement. These two methods are becoming more popular and widely used in cardiovascular medicine 40, 41) For example, incorporating the homocysteine level into the FRS was evaluated by the NRI 42) , since the inclusion of a new biomarker to the existing CHD risk score changed the predictability of events in a very marginal manner (less than 0.01 of the AUC) 43) , and an enormously large odds ratio is needed for significant improvement 44, 45) . Clinicians currently do not have a tool for evaluating the CHD risk of patients with CKD but with relatively few other risk factors. These patients might be misjudged as having a very low risk.
Recently, an individualized risk prediction tool including more diverse risk factors increased 43% AMI and Strokes at the same cost 46) . Therefore, we believe that the inclusion of CKD in the prediction score is necessary and effective for populations at high risk for CHD. Currently, there are estimated to be more than 11 million CKD patients in Japan 47) , and people have little doubt that CKD has a major impact on the population's health.
Our population had higher risks for developing CHD compared to other Japanese cohorts. The Suita cohort population was selected from an urban population, in contrast to the majority of other cohorts in Japan, which have been selected mainly from rural populations. Because approximately 66% of the Japanese population lives in urban areas according to 2006 Japanese Census 48) , this is an important feature of our analysis. Interestingly, the JMS cohort and JALS reported that the crude incidence of AMI was 0.68 and 0.60 per 1000 person-years, respectively 11, 14, 15, 49) . On the contrary, the crude incidence of AMI in the Suita study was 1.40 50) . These findings may suggest that there is a large difference in the incidence of CHD between rural and urban areas in Japan. Thus, our tool is more useful for predicting the risk in urbanized populations with a higher risk of CHD.
Our study is associated with several limitations. First, the single assessment of risk factors at the baseline survey may have led to a regression dilution bias 51) . Second, the response rate of the original cohort was 53.1% (6,825/ 12,200) although the participants
